Lab Manager Academy Subscribe to Lab Manager

CN Bio

CN Bio is a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery. With more than a decade of research and development experience in multi-organ microphysiology, the company aims to transform the way human-relevant pre-clinical data is generated.

Articles by CN Bio

CN Bio PhysioMimix™ OOC Multi-Organ Microphysiological System

CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System

Mar 23, 2021 by CN Bio

System to be launched at Society of Toxicology’s 2021 Virtual Annual Meeting, March 12-26th, 2021

single and multi-organ models for COVID-19 research

CN Bio Awarded Innovate UK Grant to Develop Single and Multi-Organ Models for COVID-19 Research

Mar 05, 2021 by CN Bio

The funding will be used to develop and test advanced cell culture models that represent different regions of the lung

CN Bio’s PhysioMimix Technology Receives FDA Recognition

CN Bio’s PhysioMimix Technology Receives FDA Recognition

Jan 14, 2021 by CN Bio

FDA publication demonstrates advantages of PhysioMimix in drug safety and metabolism applications over standard techniques

CN Bio to provide drug metabolism and safety toxicity testing services

CN Bio to Provide Drug Metabolism and Safety Toxicity Testing Services

Nov 06, 2020 by CN Bio

Extended range of services supports accelerated drug discovery and development using predictive 3D Liver-on-Chip technology